In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults. - Wikidata - awgldk - TriplyDB

In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults.

In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults.

http://www.wikidata.org/entity/Q34865982

about

Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation Functional network endophenotypes unravel the effects of apolipoprotein E epsilon 4 in middle-aged adults Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex.Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study.Diagnostic utility of amyloid PET in cerebral amyloid angiopathy-related symptomatic intracerebral hemorrhage.Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration.Mild to moderate Alzheimer dementia with insufficient neuropathological changes.Mild cognitive impairment and asymptomatic Alzheimer disease subjects: equivalent β-amyloid and tau loads with divergent cognitive outcomes.Neuropathologic assessment of dementia markers in identical and fraternal twins.Assessment of amyloid β in pathologically confirmed frontotemporal dementia syndromes.Brain imaging in the study of Alzheimer's disease Molecular imaging of Alzheimer disease pathology Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum.Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia.Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review.Multimodality imaging characteristics of dementia with Lewy bodies.Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta.Correspondence between in vivo (11)C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques.Biomarkers for the clinical evaluation of the cognitively impaired elderly: amyloid is not enough.Postmortem Pittsburgh Compound B (PiB) binding increases with Alzheimer's disease progression.Translational research in neurology: dementia.Brain β-amyloid load approaches a plateau Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association Amyloid-β positron emission tomography imaging probes: a critical review.In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain.Disclosure of amyloid imaging results to research participants: has the time come?Cerebral amyloid PET imaging in Alzheimer's disease.Memory decline shows stronger associations with estimated spatial patterns of amyloid deposition progression than total amyloid burden.Regional correlations between [11C]PIB PET and post-mortem burden of amyloid-beta pathology in a diverse neuropathological cohort.Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection.Biomarker modeling of Alzheimer's disease.Amyloid imaging in Alzheimer's disease: a literature review.Imaging Amyloidopathy in Parkinson Disease and Parkinsonian Dementia Syndromes.Biomarkers for the Early Detection and Progression of Alzheimer's Disease.Biomarkers in Neurodegenerative Diseases.Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease.

P2860

Q27009411-4C4BEA7B-DE0B-4A13-BE43-CDCBF4F17C1F Q27303745-E723AA8B-49F0-496A-8D5C-E89DE35AEE55 Q28394313-3C035724-9B5E-48C4-BB8F-52C4A43E4269 Q29620245-B35AE26B-EB52-4A37-9AE7-3A1209FF5116 Q30100986-47DCC32B-E0B3-473F-997F-1C418AAA1ED9 Q30422060-15D653EE-C38B-4944-81E0-81B42A20D3FC Q33581237-78662581-01F4-42ED-9350-40F23A0135DE Q33581412-C1AAAEBB-E236-4818-AF46-03CFC48246C1 Q33592693-6E702AC0-470C-407B-83B1-94D94023EEBB Q33772805-DFE648B9-8161-4B9C-9704-DB873F360520 Q33784747-F4AB61FD-E9F7-4880-BA23-9DD28161E22D Q33806930-73248D18-155A-4D62-A18B-27B65A032859 Q34102331-4725D04B-9D0A-4F37-A67A-5D76369F5D1A Q34651135-2FF40B2A-7C5F-4F92-B00C-C57C209FFB6C Q35529715-114CE31C-26C5-46CF-AE09-502A68CB5C34 Q35592672-ACECD086-AC0D-4716-9BA8-66345231E828 Q35600979-669E36EC-8273-44AE-9B8C-C14BA67185CA Q35603195-119BA10C-8D34-4D1D-9F42-E3C8929691A0 Q35785744-E3DFDACE-7CC3-4B42-8401-183A3F41BFF9 Q36526176-5F1AA43C-5D25-4467-BEEE-8CD3C3F9366D Q36592191-2BFBADA6-35E7-4BB6-BB80-9275726BFFF9 Q36612922-09562D50-E275-4964-8162-3748917255E1 Q36713678-D3B987F2-466B-4AF1-AB21-BF951C0EB9A2 Q36817161-3538530C-2627-4B42-AD1A-2910B90BDD35 Q36841536-551AF4EE-646C-409D-A6B3-C8612AC0F58C Q37069527-03CF270A-77E9-4A24-9CC5-35354EF721D2 Q37086266-E7620DCB-3F85-4761-86EF-F56EC2C815F5 Q37096041-0054CF05-A3C2-4ABA-845D-A7E53B1366D3 Q37135140-7F08558D-0C73-4B52-8843-D03B5C4DC196 Q37459083-4A097E38-5DB9-48F9-B15D-00F7FC3C6FF4 Q37483328-CEFE9684-E6B6-433B-852C-568F8C79922B Q37485059-BDF4363F-3ACC-4727-932A-917892477FC7 Q37498339-E64261C9-0368-4F0E-B0C5-7DCD7C8F033F Q37592824-26CD7F42-1D5F-4B58-919E-4D896D5E8493 Q38250091-62C06F9F-C6CA-40DD-BA62-1164410AB917 Q38368611-CAB3BCFB-02C6-4390-BF58-81B2D546150A Q38979999-EB582AA8-95CD-4739-9DDE-7474D46CC4FD Q39413097-6E4818EA-687E-4F67-BC16-04DA209C6195 Q39613391-701C2FB6-A484-4249-B8CF-FBE0A4BD258D Q43058539-21E8BC12-EDCD-4FF1-9E9B-CC5501FF57BB

P2860

In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults.

http://www.wikidata.org/entity/Q34865982

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

In vivo fibrillar beta-amyloid ...... ic assessment in older adults.

@ast

In vivo fibrillar beta-amyloid ...... ic assessment in older adults.

@en

In vivo fibrillar beta-amyloid ...... ic assessment in older adults.

@nl

type

label

In vivo fibrillar beta-amyloid ...... ic assessment in older adults.

@ast

In vivo fibrillar beta-amyloid ...... ic assessment in older adults.

@en

In vivo fibrillar beta-amyloid ...... ic assessment in older adults.

@nl

prefLabel

In vivo fibrillar beta-amyloid ...... ic assessment in older adults.

@ast

In vivo fibrillar beta-amyloid ...... ic assessment in older adults.

@en

In vivo fibrillar beta-amyloid ...... ic assessment in older adults.

@nl

P1433

Q34865982-B1BF2B58-8D81-41B3-BBB8-6C3DA4B0EDC7

P1476

Q34865982-CDD6ACFA-93CD-45AD-BB66-28922555B5C6

P2093

Q34865982-0F6B9928-E36B-43A0-ACB0-B0C6F29C9345

Q34865982-3950EB60-A489-4043-9536-E4C56DA214ED

Q34865982-3C865FC8-40EE-4D8B-A087-6DAD191066DC

Q34865982-3DD9AD70-9013-4C6C-AEBE-4C0FBCE74568

Q34865982-7313997F-8EE8-4884-B35E-8FE6B5237D59

Q34865982-8867984C-C28A-4CBC-94F2-8E3E337F9B83

Q34865982-8D99649F-35A3-4709-8CF7-A8FF4D1A51CB

Q34865982-90ED7EAE-ECB9-4757-895B-A3A5681D11B0

Q34865982-9249B64F-3A65-429C-A3D7-DFAE5972C66D

Q34865982-B96281C8-B2F5-4873-B3BD-68FC99C266BC

P2860

Q34865982-015DF987-7522-4409-9ECD-34179122C024

Q34865982-0ABE7BC9-97AA-4E6B-9904-0855A1FBA3EA

Q34865982-25DE269D-60C4-4B56-9585-3FF3F809C976

Q34865982-363A1011-AB1A-4EBF-8CE9-A867C1F73631

Q34865982-3671205B-632B-4A7F-9603-32FAF2B41C5E

Q34865982-3EC85375-759B-4516-A47F-8F9741FDE1DF

Q34865982-4EF81DDA-9D80-4718-AF09-738A6BBF9763

Q34865982-59CD5521-8F13-4002-A94D-67A44F36A26E

Q34865982-6F784348-533B-4B9F-9A97-3464E1B662CB

Q34865982-70A01ABC-49A4-4762-8C32-078ADC43B797

P304

Q34865982-E414F307-37FA-4F98-8A83-41B8885449FB

P31

Q34865982-0CDCE6B0-1E39-44B9-86ED-082109D34BD3

P356

Q34865982-27906924-9480-4888-BBA6-723233F51904

P433

Q34865982-2AC813CE-4494-4C94-8FFB-A1F9279F32D7

P478

Q34865982-1239DA19-1C75-4109-B67A-F238E162F215

P50

Q34865982-9AAAE49E-CBC4-4429-9943-76F4C1238334

Q34865982-CBC459CA-A9AD-48CC-84E7-6D07567B7EA2

P577

Q34865982-B3F7996A-1347-4363-A4F3-840C7920D12F

P5875

Q34865982-8992FDDB-CC48-42BE-A2E7-9CB8661CD909

P698

Q34865982-4CC6C653-AEEC-4C80-9977-296AE861C0C6

P932

Q34865982-9AD96EEE-0A2A-4484-9404-6434B9468C29

P356

ARCHNEUROL.2010.357

P1433

P1476

In vivo fibrillar beta-amyloid ...... ic assessment in older adults.

@en

P2093

Chester A Mathis

http://www.w3.org/2001/XMLSchema#string

Dean F Wong

http://www.w3.org/2001/XMLSchema#string

Diego Iacono

http://www.w3.org/2001/XMLSchema#string

Ira Driscoll

http://www.w3.org/2001/XMLSchema#string

Jitka Sojkova

http://www.w3.org/2001/XMLSchema#string

Juan C Troncoso

http://www.w3.org/2001/XMLSchema#string

Kari-Elise Codispoti

http://www.w3.org/2001/XMLSchema#string

Michael A Kraut

http://www.w3.org/2001/XMLSchema#string

Olga Pletnikova

http://www.w3.org/2001/XMLSchema#string

Richard J O'Brien

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake

Neuropathological stageing of Alzheimer-related changes

Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's disease

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.

Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease

Mild cognitive impairment: current research and clinical implications.

Frequent amyloid deposition without significant cognitive impairment among the elderly.

Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report.

Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.

P304

232-240

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHNEUROL.2010.357

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P50

William E. Klunk

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49835983

http://www.w3.org/2001/XMLSchema#string

P698

21320990

http://www.w3.org/2001/XMLSchema#string

P932

3082956

http://www.w3.org/2001/XMLSchema#string